Alibaba Emerges From Regulatory Scrutiny

Robert Way Investment Thesis Despite the recent gains since our last coverage, Alibaba Group (NYSE:BABA) (OTCPK:BABAF) remains pressured by the global "Avoid China" / value trap sentiment. Investor skepticism continues to weigh on the stock, impacting its valuation and global expansion. However, completing Alibaba's three-year regulatory rectification after its 2021 antitrust delicate signals the potential for a narrative shift. As China bolsters Alibaba's domestic growth, regulatory concerns are easing, cr ...